“Brad did a wonderful job managing the development and validation of several analytical assays via a government contract for a recombinant protein vaccine. He joined the company after the assays had failed to be validated. He was instrumental in troubleshooting the assay problems so that they could be successfully validated, which was a critical milestone of that particular government contract. Specifically, his expert knowledge on protein structure and function as well as his overall analytical method skills were very much evident. It was a pleasure to work with Brad as the QA representative on the project. I would happily work with Brad again- I learned a lot from him!”
Bradford Powell, Ph.D. PMP
Frederick, Maryland, United States
904 followers
500+ connections
About
Pharmaceutical and Biological products quality professional with experience in…
Experience
Licenses & Certifications
-
-
Project Management Professional (PMP)
Project Management Insititute
Patents
-
Prophylactic and therapeutic monoclonal antibodies
Issued US 7,718,779
In this application are described monoclonal antibodies which specifically recognize V antigen of Y. pestis and epitopes recognized by these monoclonal antibodies. Also provided are mixtures of antibodies of the present invention, as well as methods of using individual antibodies or mixtures thereof for the detection, prevention, and/or therapeutical treatment of plague infections in vitro and in vivo.
Other inventors -
-
Methods of screening for agents that delay a cell cycle and compositions comprising Era and an analogue of wild-type Era
Issued US 6,132,954
The present invention provides for methods of screening for agents which delay the cell cycle and methods of delaying the cell cycle. Analogues of Era having arginine, histidine, or lysine at amino acid codon 17 are embodied by the present invention. Human and other homologs of bacterial Era amino acid and nucleic acid sequences are provided in the present invention. Vectors, host cells, protein preparations, cell cultures, and compositions comprising said analogue are also set forth in the…
The present invention provides for methods of screening for agents which delay the cell cycle and methods of delaying the cell cycle. Analogues of Era having arginine, histidine, or lysine at amino acid codon 17 are embodied by the present invention. Human and other homologs of bacterial Era amino acid and nucleic acid sequences are provided in the present invention. Vectors, host cells, protein preparations, cell cultures, and compositions comprising said analogue are also set forth in the present invention.
Other inventors -
Organizations
-
American Association of Laboratory Accreditation, ATCC® Standards Development Organization (workgroup member), American Chemical Society, American Society for Mass Spectrometry, American Society for Microbiology
-
Recommendations received
20 people have recommended Bradford
Join now to viewOther similar profiles
Explore collaborative articles
We’re unlocking community knowledge in a new way. Experts add insights directly into each article, started with the help of AI.
Explore More